SARS-CoV-2 infection, which causes the respiratory disease COVID-19, has spread rapidly from Wuhan, China, since 2019, causing nearly 7 million deaths worldwide in three years. In addition to clinical risk factors such as diabetes, hypertension, and obesity, genetic variability is an important predictor of disease severity and susceptibility. We analyzed common polymorphisms within the LZTFL1 (rs11385942) and ABCA3 (rs13332514) genes in 519 SARS-CoV-2-positive subjects (164 asymptomatic, 246 symptomatic, and 109 hospitalized COVID-19 survivors) and a population-based control group (N?=?2,592; COVID-19 status unknown). Rare ABCA3 AA homozygotes (but not A allele carriers) may be at a significantly increased risk of SARS-CoV-2 infection [P?=?0.003; OR (95 % CI); 3.66 (1.47-9.15)]. We also observed a borderline significant difference in the genotype distribution of the LZTFL1 rs11385942 polymorphism (P?=?0.04) between the population sample and SARS-CoV-2-positive subjects. In agreement with previous studies, a nonsignificantly higher frequency of minor allele carriers was detected among hospitalized COVID-19 subjects. We conclude that a common polymorphism in the ABCA3 gene may be a significant predictor of susceptibility to SARS-CoV-2 infection.

Clinic of Rheumatology and Physiotherapy 3rd Faculty of Medicine Charles University and Thomayer University Hospital Prague Czech Republic

Department of Endocrinology and Metabolism 3rd Department of Internal Medicine 1st Faculty of Medicine Charles University and General University Hospital Prague Czech Republic

Department of Preventive Cardiology Institute for Clinical and Experimental Medicine Prague Czech Republic

Experimental Medicine Centre Institute for Clinical and Experimental Medicine Prague Czech Republic

Institute of Biostatistics and Analyses Faculty of Medicine Masaryk University Brno Czech Republic

Institute of Health Information and Statistics of the Czech Republic Prague Czech Republic

000      

00000naa a2200000 a 4500

001      

bmc23018214

003      

CZ-PrNML

005      

20231116090700.0

007      

ta

008      

231107s2023 xr a f 000 0|eng||

009      

AR

035    __

$a (PubMed)37795896

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a xr

100    1_

$a Hubacek, Jaroslav A. $u Experimental Medicine Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic $u Department of Endocrinology and Metabolism, Third Department of Internal Medicine, First Faculty of Medicine, Charles University & General University Hospital, Prague, Czech Republic

245    10

$a ABCA3 and LZTFL1 Polymorphisms and Risk of COVID-19 in the Czech Population / $c JA. Hubacek, T. Philipp, V. Adamkova, O. Majek, L. Dusek

520    9_

$a SARS-CoV-2 infection, which causes the respiratory disease COVID-19, has spread rapidly from Wuhan, China, since 2019, causing nearly 7 million deaths worldwide in three years. In addition to clinical risk factors such as diabetes, hypertension, and obesity, genetic variability is an important predictor of disease severity and susceptibility. We analyzed common polymorphisms within the LZTFL1 (rs11385942) and ABCA3 (rs13332514) genes in 519 SARS-CoV-2-positive subjects (164 asymptomatic, 246 symptomatic, and 109 hospitalized COVID-19 survivors) and a population-based control group (N?=?2,592; COVID-19 status unknown). Rare ABCA3 AA homozygotes (but not A allele carriers) may be at a significantly increased risk of SARS-CoV-2 infection [P?=?0.003; OR (95 % CI); 3.66 (1.47-9.15)]. We also observed a borderline significant difference in the genotype distribution of the LZTFL1 rs11385942 polymorphism (P?=?0.04) between the population sample and SARS-CoV-2-positive subjects. In agreement with previous studies, a nonsignificantly higher frequency of minor allele carriers was detected among hospitalized COVID-19 subjects. We conclude that a common polymorphism in the ABCA3 gene may be a significant predictor of susceptibility to SARS-CoV-2 infection.

650    _2

$a lidé $7 D006801

650    12

$a COVID-19 $x diagnóza $x epidemiologie $x genetika $7 D000086382

650    _2

$a SARS-CoV-2 $7 D000086402

650    _2

$a polymorfismus genetický $7 D011110

650    _2

$a genotyp $7 D005838

650    _2

$a transkripční faktory $x genetika $7 D014157

650    _2

$a ABC transportéry $x genetika $7 D018528

651    _2

$a Česká republika $7 D018153

655    _2

$a časopisecké články $7 D016428

700    1_

$a Philipp, Tom, $d 1968- $7 jn20000401983 $u Clinic of Rheumatology and Physiotherapy, Third Faculty of Medicine, Charles University & Thomayer University Hospital, Prague, Czech Republic

700    1_

$a Adámková, Věra, $d 1954- $7 jx20050329003 $u Department of Preventive Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic

700    1_

$a Májek, Ondřej, $d 1985- $7 xx0156444 $u Institute of Health Information and Statistics of the Czech Republic, Prague, Czech Republic $u Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic

700    1_

$a Dušek, Ladislav, $d 1967- $7 mzk2003181727 $u Institute of Health Information and Statistics of the Czech Republic, Prague, Czech Republic $u Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic

773    0_

$w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 72, č. 4 (2023), s. 539-543

856    41

$u https://pubmed.ncbi.nlm.nih.gov/37795896 $y Pubmed

910    __

$a ABA008 $b A 4120 $c 266 $y p $z 0

990    __

$a 20231107 $b ABA008

991    __

$a 20231116090655 $b ABA008

999    __

$a ok $b bmc $g 2009492 $s 1204617

BAS    __

$a 3

BAS    __

$a PreBMC-MEDLINE

BMC    __

$a 2023 $b 72 $c 4 $d 539-543 $e 2023Aug31 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824

LZP    __

$b NLK198 $a Pubmed-20231107